General MedicationsINJECTIONGeneric
PROSTIN F2 ALPHA
DINOPROST TROMETHAMINE
Standard Dose
EQ 5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview PROSTIN F2 ALPHA is listed in Drugs@FDA under application 017434 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient DINOPROST TROMETHAMINE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1983-12-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROSTIN F2 ALPHA is listed in Drugs@FDA under application 017434 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient DINOPROST TROMETHAMINE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1983-12-05 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.